Preparation method and application of human ptx3 recombinant protein

A recombinant protein and human technology, which is applied in the field of preparation of human recombinant protein, can solve the problem that the technical level of CHO-K1 cells expressing foreign genes cannot meet the requirements of the development and production of biopharmaceuticals, low production efficiency of recombinant CHO-K1 cells, sugar Insufficient stability of ylated expression products, etc., to achieve the effects of increasing the survival time, high RNA extraction yield, and increasing the success rate

Active Publication Date: 2019-01-29
WUHAN NCE BIOMEDICAL CO LTD
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] In the past few decades, humans have carried out a lot of research and development on animal cell culture technology, and made great progress, but the technical level of using CHO-K1 cells to express foreign genes is still not enough for the development and production of biopharmaceuticals. requirements, the current upstream work mainly has the following problems:
[0007] ①The constructed recombinant CHO-K1 cells have low production efficiency and low product concentration;
[0008] ② Certain glycosylated expression products are unstable and difficult to purify;
[0010] ④Recombinant cell culture is expensive and the level of automation is low

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method and application of human ptx3 recombinant protein
  • Preparation method and application of human ptx3 recombinant protein
  • Preparation method and application of human ptx3 recombinant protein

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0055] A method for preparing human PTX3 recombinant protein of the present invention, said method comprising the following steps:

[0056] S1. Extract mRNA carrying PTX3 protein translation information from human primary epithelial cells, design specific primers, use the mRNA as a template, synthesize cDNA, and introduce restriction enzyme sites at both ends of the cDNA BamH I and Bg1 II;

[0057] S2, exposing the sticky ends of BamH I and Bg1 II on the eukaryotic cell expression vector pSG5 with endonuclease, and cloning the above-mentioned cDNA with the ends of BamH I and Bg1 II into the expression vector to construct pSG5 / PTX3 vector , inserting a neomycin resistance gene into the pSG5 / PTX3 vector to construct a recombinant vector pSG5 / neo- / PTX3;

[0058] The neomycin resistance gene was inserted into the expression vector pSG5 / PTX3 to form a pSG5 / PTX3 / neo recombinant expression vector, and the stable transfected CHO-K1 cells were selected by neomycin resistance. Only ce...

Embodiment 1

[0084] Example 1: Construction of vector pSG5 / PTX3 / neo

[0085] 1. Construction of pSG5 / PTX3

[0086] 1.1 Preparation of PTX3 gene fragment

[0087] The TRIzol method was used to extract total RNA from primary human epithelial cells. The total RNA contains mRNA carrying human PTX3 protein information; according to the human PTX3 mRNA sequence published on the GenBank website, specific primers are designed, and the PTX3 mRNA in the total RNA is used as a template to synthesize cDNA. And respectively introduce restriction enzyme sites BamH I and Bg1 II at both ends of the cDNA, the specific steps are as follows:

[0088] Reverse transcription polymerase chain reaction (RT-PCR)

[0089] A pair of primers (P1 and P2) were designed, the restriction enzyme cutting site BamH I was introduced into the upstream primer, and the restriction enzyme cutting site Bg1 II was introduced into the downstream primer. Under the action of reverse transcriptase, the first strand of cDNA (SEQ ID...

Embodiment 2

[0110] Embodiment 2: the method for purifying recombinant human PTX3 protein:

[0111] The culture supernatant from the fermentor was loaded onto a Q-Sepharose™ Fast Flow (GE Healthcare, UK) packed column. The remaining material is eluted using a nonlinear gradient. The eluate containing PTX3 was directly applied to ceramic hydroxyapatite (BioRad, Hercules, CA, USA) and packed into a column. The remaining material is eluted in a non-linear fashion by increasing the phosphate concentration. The eluate containing PTX3 was concentrated and buffer exchanged on an ultrafiltration membrane (Pellicon-Biomax 100, Millipore) followed by purification by size exclusion chromatography on a Biosep-SEC-S4000 (Phenomenex). Finally, the PTX3 eluate was concentrated with an ultrafiltration membrane (Pellicon-Biomax 100, Millipore).

[0112]After Western blot (WB) result analysis, after purification, the recovery rate of PTX3 recombinant protein reaches 69%, and the purity reaches 95%, as ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
recovery rateaaaaaaaaaa
Login to View More

Abstract

The invention provides a preparing method and application of a human PTX3 recombinant protein. The method comprises the steps: constructing a eukaryocyte expression vector of the human PTX3 recombinant protein, knocking out apoptosis promoting factors in CHO-K1 cells, performing a calcium phosphate transfection program and performing enrichment and purifying of the human PTX3 recombinant protein. The vector capable of stably highly expressing protein in cells of mammal animals is constructed, and through antibiotic screening and improvement of conditions of a culture solution, an establishing yield is higher and expression is stable.

Description

technical field [0001] The present invention relates to a preparation method of human recombinant protein, in particular to the preparation method and application of human PTX3 recombinant protein. technical background [0002] Pentaxin 3 (PTX3) is one of the members of the pentaxin protein family and belongs to the long-chain pentameric protein. PTX3 is a kind of acute phase response protein. Studies have shown that PTX3 is a soluble pathogen pattern recognition receptor (PRR), which can quickly and selectively recognize and bind to invading foreign pathogens, which is to stimulate the body's innate immunity and secondary immune response, thereby clearing the invading pathogens The crucial first step. At the same time, cell culture and animal models have confirmed that PTX3 can selectively bind certain pathogens with high affinity, including cytomegalovirus (CMV), influenza virus (Influenza), murine hepatitis virus (MHV), Salmonella typhimurium and aeruginosa The combina...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityPatents(China)
IPC IPC(8): C12N15/85C12N15/12C07K14/705A61K38/17A61P31/14
CPCY02A50/30
Inventor韩兵王烁冯玉冰万君花
OwnerWUHAN NCE BIOMEDICAL CO LTD